SCHEMBL2838019

SCHEMBL2838019

Nc1ccc(Br)cc1-c1nnn[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.57
GPR35 Q9HC97 2/20 0.53
MAPT P10636 5/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
HTT P42858 2/20 0.38
PDPK1 O15530 2/20 0.36
JAK2 O60674 2/20 0.36
ALDH1A1 P00352 3/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.35
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
TGM2 P21980 1/20 0.33
CES1 P23141 1/20 0.33
PABPC1 P11940 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30192181 1.00 IDO1 (0.57) IDO1GPR35MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL7570994 0.98 IDO1 (0.55) IDO1GPR35MAPTMEN1KMT2A
SCHEMBL1463479 0.79 IDO1 (0.57) IDO1ALDH1A1TSHRMAPK1HSD17B10
SCHEMBL3277817 0.79 IDO1 (0.35) IDO1GPR35TGM2CES1
SCHEMBL4021639 0.77 IDO1 (0.33) IDO1GPR35MAPTKMT2AHTT
SCHEMBL3273478 0.76 DGAT1 (0.45) IDO1GPR35KMT2AKDM4EGLA
SCHEMBL10254523 0.76 GPR35 (0.35) IDO1GPR35TSHRRAB9AKDM4E
SCHEMBL1629842 0.76 ALOX5AP (0.36) IDO1GPR35MAPTMEN1KMT2A
SCHEMBL13404775 0.76 JAK2 (0.41) MAPTMEN1KMT2AHTTJAK2
SCHEMBL27363041 0.76 ALDH1A1 (0.42) MAPTMEN1KMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4182303-B1 THERMODYNAMICALLY STABLE FORM OF SCO-101 SCANDION ONCOLOGY AS (DK) 2023-11-29 EP claimed
US-20100087496-A1 NOVEL CINNAMIC AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-04-08 US claimed
EP-2155700-B1 BETA-KETO-AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS NEUROSEARCH AS (DK) 2010-10-06 EP disclosed
US-20100144736-A1 NOVEL BIPHENYL THIO-UREA DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-06-10 US disclosed
US-20100144736-A1 NOVEL BIPHENYL THIO-UREA DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-06-10 US disclosed
US-20100144736-A1 NOVEL BIPHENYL THIO-UREA DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-06-10 US disclosed
US-20100137381-A1 ACETAMIDE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-06-03 US disclosed
US-20100137387-A1 BETA-KETO-AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-06-03 US disclosed
US-20100087496-A1 NOVEL CINNAMIC AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-04-08 US disclosed
EP-2155700-A1 BETA-KETO-AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS NeuroSearch A/S (DK) 2010-02-24 EP disclosed
EP-2152677-A1 ACETAMIDE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS NeuroSearch A/S (DK) 2010-02-17 EP disclosed
WO-2004022529-A2 DIARYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS NEUROSEARCH A/S (DK) 2004-03-18 WO disclosed
US-6696475-B2 N-PHENYL-N'-(2-CARBOXYPHENYL) UREA, FOR EXAMPLE; CHLORIDE CHANNEL BLOCKERS; SUCH AS FOR TREATING BONE METABOLIC DISORDERS NEUROSEARCH A/S (DK) 2004-02-24 US disclosed
EP-0977741-B1 SUBSTITUTED PHENYL DERIVATIVES, THEIR PREPARATION AND USE NEUROSEARCH AS (DK) 2003-09-03 EP disclosed
CN-1118462-C Substituted phenyl derivatives, their preparation and use NEUROSEARCH AS (DK) 2003-08-20 CN disclosed
US-20020037905-A1 Substituted phenyl derivatives, their preparation and use ANIONA APS (DK) 2002-03-28 US disclosed
US-6297261-B1 POTENT CHLORIDE CHANNEL BLOCKERS; TREATMENT OF SICKLE CELL ANEMIA, BRAIN EDEMA FOLLOWING ISCHAEMIA OR TUMORS, DIARRHEA, HYPERTENSION (DIURETIC), OSTEOPOROSIS, AND FOR THE REDUCTION OF THE INTRAOCULAR PRESSURE NEUROSEARCH A/S (DK) 2001-10-02 US disclosed
CN-1253553-A Substituted phenyl derivatives, their preparation and use NEUROSEARCH AS (DK) 2000-05-17 CN disclosed
EP-0977741-A1 SUBSTITUTED PHENYL DERIVATIVES, THEIR PREPARATION AND USE NEUROSEARCH A/S (DK) 2000-02-09 EP disclosed
WO-1998047879-A1 SUBSTITUTED PHENYL DERIVATIVES, THEIR PREPARATION AND USE NEUROSEARCH A/S (DK) 1998-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137387-A1 BETA-KETO-AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS KCNAB1, KCNJ2, KCNN3 IDO1 4173/4885GPR35 1406/4885MAPT 2006/4885
US-20100087496-A1 NOVEL CINNAMIC AMIDE DERIVATIVES USEFUL AS ION CHANNEL MODULATORS TRPV1, TRPA1, TRPM8 IDO1 4497/4885GPR35 1129/4885MAPT 1755/4885
US-20020037905-A1 Substituted phenyl derivatives, their preparation and use KCNB1, KCNH2, KCNJ2 IDO1 2512/4885GPR35 952/4885MAPT 3787/4885
US-20100137381-A1 ACETAMIDE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS KCNJ2, KCNJ1, KCNN2 IDO1 4391/4885GPR35 1562/4885MAPT 1884/4885
US-20100144736-A1 NOVEL BIPHENYL THIO-UREA DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS KCNJ1, KCNJ2, KCNB1 IDO1 2360/4885GPR35 991/4885MAPT 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.